Selected Disorders of the Female Reproductive System

  • Gary R. Newkirk


Pelvic inflammatory disease (PID) is a clinical syndrome comprising infection and inflammation of the upper genital tract; it encompasses endometritis, salpingitis, tuboovarian abscess, and pelvic peritonitis.1 One million women a year are treated for acute PID at an annual cost of more than $4 billion.2 At least one-fourth of women with PID suffer serious sequelae (infertility, ectopic pregnancy, chronic pelvic pain) and are at risk for major abdominal or pelvic surgery (tuboovarian abscess, pelvic adhesive disease). Teenagers comprise one-fifth of the total cases, and the rate for adolescent girls has continued to rise, especially for white girls.3,4


Ectopic Pregnancy Pelvic Inflammatory Disease Toxic Shock Syndrome Infertile Couple Female Reproductive System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Antimicrobial therapy for gynecologic infections. Technical Bulletin No. 153. Washington, DC: American College of Obstetricians and Gynecologists, 1991.Google Scholar
  2. 2.
    Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000. JAMA 1991;266:2565–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Washington AE, Sweet RL, Shafer MA. Pelvic inflammatory disease in the adolescent female and its sequelae. J Adolesc Health Care 1985;6:298–310.PubMedCrossRefGoogle Scholar
  4. 4.
    Shafer MA, Sweet RL. Pelvic inflammatory disease in adolescent females: epidemiology, pathogenesis, diagnosis, treatment, and sequelae. Pediatr Clin North Am 1989;36:513–31.PubMedGoogle Scholar
  5. 5.
    Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707–13.PubMedGoogle Scholar
  6. 6.
    Holmes KK, Eschenbach DA, Knapp JS: Salpingitis: overview of etiology and epidemiology. Am J Obstet Gynecol 1980;138:893–900.PubMedGoogle Scholar
  7. 7.
    Eschenback DA. Acute pelvic inflammatory disease. Urol Clin North Am 1984;11:65–81.Google Scholar
  8. 8.
    Wolner-Hanssen P, Eschenback DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990;263:1936–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Vermesh M, Confino E, Boler LR, Freiberg J, Gleicher N. Acute salpingitis in sterilized women. Obstet Gynecol 1987;69:265–7.PubMedGoogle Scholar
  10. 10.
    Wolner-Hanssen P, Kiviat NB, Holmes KK. Atypical pelvic inflammatory disease: subacute, chronic, or subclinical upper genital tract infection in women. In: Holmes KK, Mardh P-A, Sparling PF, et al, editors. Sexually Transmitted Diseases. 2nd ed. New York: McGraw-Hill, 1989:615–20.Google Scholar
  11. 11.
    Shepard MK, Jones RB. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertil Steril 1989;52:232–8.PubMedGoogle Scholar
  12. 12.
    Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: diagnostic and prognostic value of routine laparoscopy Am J Obstet Gynecol 1969;105:1088–98.PubMedGoogle Scholar
  13. 13.
    Hager WD, Eschenback DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61:113–4.PubMedGoogle Scholar
  14. 14.
    Hinman AR, Cates W Jr. Pelvic inflammatory disease: guidelines for prevention and management; and Hinman AR, Snider DE, O’Brien RJ, purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40:1–25.Google Scholar
  15. 15.
    Burnakis TG, Hildebrandt NB. Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy. Rev Infect Dis 1986;8:86–116.PubMedCrossRefGoogle Scholar
  16. 16.
    Crombleholme WR, Schacter J, Ohm-Smith M, Luft J, Whhidden R, Sweet RL. Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. Am J Med 1989;87:142s-7s.CrossRefGoogle Scholar
  17. 17.
    Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991;266:2574–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Berg AO. The primary care physician and sexually transmitted disease control. In: Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ, editors. Sexually transmitted disease. 2nd ed. New York: McGraw-Hill, 1990:1095–8.Google Scholar
  19. 19.
    Sampson, JA. Perforating hemorrhagic (chocolate) cysts of the ovary, their importance and especially their relation to pelvic adenomas of the endometrial type. Arch Surg 1921;3:254–323.CrossRefGoogle Scholar
  20. 20.
    Saltiel E, Garabedian-Ruffalo SM. Pharmacologic management of endometriosis. Clin Pharm 1991;10:518–30.PubMedGoogle Scholar
  21. 21.
    Dawood MY. Endometriosis. In: Gold JJ, Josimovich JB, editors. Gynecologic endocrinology. New York: Plenum, 1987:387–404.CrossRefGoogle Scholar
  22. 22.
    Moghissi KS. Office management of endometriosis. In: Sten-chever MA, editor. Office gynecology. St. Louis: Mosby Year Book, 1992:413–29.Google Scholar
  23. 23.
    National Center for Health Statistics, McCarthey E. Inpatient utilization of short-stay hospitals by diagnosis: United States, 1980. Hyattsville, MD: National Center for Health Statistics, 1982; DHSS Publ. No. (PHS) 83–1735. (Vital and health statistics; series 13: Data from the National Health Survey, no. 74.)Google Scholar
  24. 24.
    Hurst BS, Rock JA. Endometriosis: pathophysiology, diagnosis, and treatment. Obstet Gynecol Surv 1989:44:297–304.PubMedCrossRefGoogle Scholar
  25. 25.
    Speroff L, Glass RH, Kase NG, editors. Clinical gynecology, endocrinology, and infertility. 4th ed. Baltimore: Williams & Wilkins, 1989:547–63.Google Scholar
  26. 26.
    Dmowski WP. Endometriosis. In: Glass RH, editor. Office gynecology. Baltimore: Williams & Wilkins; 1987:317–36.Google Scholar
  27. 27.
    Management of endometriosis. Technical Bulletin No. 85. Washington, DC: American College of Obstetricians and Gynecologists, 1985.Google Scholar
  28. 28.
    Pittaway DE. CA-125 in women with endometriosis. Obstet Gynecol Clin North Am 1989;16:237–52.PubMedGoogle Scholar
  29. 29.
    Seibel MM. Does minimal endometriosis always require treatment? Contemp Obstet Gynecol 1989;34(l):27–39.Google Scholar
  30. 30.
    DiZerega GS, Barber DL, Hodgen GD. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 1980;33:649–53.PubMedGoogle Scholar
  31. 31.
    Barbieri RL. Endometriosis 1990: current treatment approaches. Drugs 1990;39:502–10.PubMedCrossRefGoogle Scholar
  32. 32.
    Overcoming endometriosis: new help from the Endometriosis Association. Milwaukee: Endometriosis Association, 1992.Google Scholar
  33. 33.
    Important facts about endometriosis. Washington, DC: American College of Obstetrics and Gynecologists, 1992.Google Scholar
  34. 34.
    Horn MC, Mosher WD. Use of services for family planning and infertility. United States, 1982, advance data from vital and health statistics, 1984; No. 103. Hyattsville, MD: US Public Health Service, Department of Health and Human Services.Google Scholar
  35. 35.
    Mosher WD. Infertility trends among U.S. couples: 1965–1976. Fam Plann Perspect 1982;14:22–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Speroff L, Glass RH, Kase NG, editors. Investigation of the infertile couple. 4th ed. Baltimore: Williams & Wilkins, 1989:513–46.Google Scholar
  37. 37.
    Zarutskie PW. Evaluation of the infertile couple. In: Stenchever MA, editor. Office gynecology. St. Louis: Mosby Year Book, 1992:441–70.Google Scholar
  38. 38.
    Infertility. Technical Bulletin No. 125. Washington, DC: American College of Obstetricians and Gynecologists; 1989.Google Scholar
  39. 39.
    Davajan V. Workup of the infertile couple. In: Mishell DR, Brenner PF, editors. Management of common problems in obstetrics and gynecology. Oradell, NJ: Medical Economics Books, 1984: 387–93.Google Scholar
  40. 40.
    RESOLVE National Headquarters, 5 Water Street, Arlington, MA 02174.Google Scholar
  41. 41.
    Todd J, Fishaut M. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978;2:1116–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Tofte RW, Williams DN. Toxic shock syndrome: evidence of a broad clinical spectrum. JAMA 1981;246:2163–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Bryner CL Jr. Recurrent toxic shock syndrome. Am Fam Physician 1989;39:157–64.PubMedGoogle Scholar
  44. 44.
    Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980;303:1429–35.PubMedCrossRefGoogle Scholar
  45. 45.
    Centers for Disease Control. Summary of notifiable disease, United States. MMWR 1988;37:40.Google Scholar
  46. 46.
    Litt IF. Toxic shock syndrome—an adolescent disease. J Adolesc Health Care 1983;4:270–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 1982;96:871–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Gallo UE, Fontanarosa PB. Toxic streptococcal syndrome. Ann Intern Med 1990;19:1332–4.Google Scholar
  49. 49.
    Resnick SD. Toxic shock syndrome: recent developments in pathogenesis. J Pediatr 1990;116:321–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis 1989;2 Suppl l:s263–9.Google Scholar
  51. 51.
    Tofte R, Williams DN. Toxic shock syndrome: clinical and laboratory features in 15 patients. Ann Intern Med 1981;94:149–56.PubMedCrossRefGoogle Scholar
  52. 52.
    Davis JP, Osterholm MT, Helms CM, et al. Tri-state toxic-shock syndrome study: clinical and laboratory findings. J Infect Dis 1982;145:441–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Todd JK. Therapy of toxic shock syndrome. Drugs 1990;39:856–61.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Gary R. Newkirk

There are no affiliations available

Personalised recommendations